1 INTRODUCTION Locally advanced pancreatic cancer (LAPC) accounts for approximately 80% of pancreatic cancer cases and is associated with a poor prognosis, with median survival of 13–24 months.1, 2 Mortality for patients with LAPC is driven by both early metastatic spread and uncontrolled local growth; an estimated 30% of patients with LAPC die with local progression alone, and an additional 10%–25% experience both local progression and distant spread before death.3, 4 Treatments that confer...